Target intelligence / Profile preview

Serratia marcescens chitinase A and B (ChiA and ChiB)

Target
ChiA and ChiB
Molecular classification
Enzyme, Glycosyl hydrolase, Family 18 chitinase
01

Overview

Serratia marcescens chitinases A and B are major enzymes involved in the breakdown of chitin, an insoluble polysaccharide found in fungal cell walls and arthropod exoskeletons. Chitinase A (ChiA) and chitinase B (ChiB) are glycosyl hydrolases from family 18, each with a distinct domain architecture. ChiB features a catalytic TIM-barrel domain and a chitin-binding domain; its action as an exochitinase allows stepwise breakdown from the nonreducing end, while ChiA complements this activity, resulting in synergistic chitin degradation[1][4]. Both chitinases are crucial components of the chitinolytic machinery secreted by S. marcescens, a Gram-negative bacterium renowned as a model system for polysaccharide conversion and as an opportunistic pathogen in humans. Chitinases have significant potential as biotechnological tools in agriculture (i.e., as antifungal agents and biopesticides) but are not currently direct targets for approved drugs.

Other names
Chitinase A (ChiA)Chitinase B (ChiB)S. marcescens chitinase AS. marcescens chitinase B
02

Mechanism of action

Hydrolysis of chitin polysaccharides by cleaving β-1,4 glycosidic bonds. ChiB: exochitinase mechanism degrading chitin from the non-reducing end. ChiA: acts synergistically with ChiB for efficient chitin breakdown

03

Biological functions

Chitin degradationPolysaccharide hydrolysisSaprophytic nutritionDefense against fungal pathogens (environmental)
04

Disease associations

Infection (mainly by S. marcescens, a potential human pathogen)Other (biotechnological use in antifungal therapy and insect control)
05

Safety considerations

S. marcescens is a known opportunistic pathogen; potential concerns where recombinant enzymes are produced in live S. marcescensOff-target effects for biopesticide use in non-target organisms (environmental safety)
06

Interacting drugs

None currently approved as drugs directly interacting with ChiA or ChiB; chitinase inhibitors (experimental)
07

Biomarkers

None in clinical use as biomarkers for S. marcescens chitinases

Beyond the preview

Go deeper on Serratia marcescens chitinase A and B (ChiA and ChiB).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Serratia marcescens chitinase A and B (ChiA and ChiB).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call